C3 p.Leu9Pro
c.26T>C · rs138214338 · VCV872465
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2413 | likely benign |
|---|---|---|
| REVEL | 0.542 | indeterminate |
| SaProt | LLR -11.73 | damaging |
| ⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 3.9 | GERP -0.4, phastCons 1 |
| Regional constraint | o/e 1.10 | unconstrained · MANE · 1,238 bp · p 0.45 · regional, not allelic |
| Overall | ||
| CADD | 21.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| European (non-Finnish)grpmax | 0.0919% | 1,088 |
| Remaining individualsnot grpmax-eligible | 0.0211% | 4,736 |
| Middle Eastern | 0.0166% | 6,042 |
| African / African-American | 0.0161% | 6,215 |
| Finnishnot grpmax-eligible | 0.0144% | 6,923 |
| Admixed American | 0.00536% | 18,639 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- C3
- Protein
- p.Leu9Pro
- Coding
- c.26T>C
- MANE Select
- NM_000064
- dbSNP
- rs138214338
- Type
- single nucleotide variant
- Location
- chr19:6720564 (GRCh38)
- Gene constraint
- LOEUF 0.541 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 79.84 · 80 PDB
Disease context
atypical hemolytic-uremic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: age related macular degeneration 9atypical hemolytic-uremic syndrome with C3 anomalycomplement component 3 deficiencyC3 glomerulonephritis
For Atypical hemolytic uremic syndrome (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive, Not applicable
- Onset
- All ages
- Prevalence
- 1-9 / 1 000 000 (United States)
Similar variants
- C3 c.1003+1G>A Pathogenic/Likely pathogenic ★★ same condition
- C3 c.2863+1G>T Likely pathogenic ★★ same condition
- C3 c.4030-2A>G Likely pathogenic ★★ same condition
- C3 p.Arg161Trp Pathogenic/Likely pathogenic ★★ ⚠ same condition
- C3 p.Arg592Gln Pathogenic/Likely pathogenic ★★ ⚠ same condition
- C3 p.Arg592Trp Likely pathogenic ★★ ⚠ same condition
- C3 p.Arg764Ter Pathogenic/Likely pathogenic ★★ same condition
- C3 p.Ile1157Thr Pathogenic/Likely pathogenic ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/c3-p-leu9pro (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown